About company
AnHeart Therapeutics is a developer of innovative pharmaceutical products. The company is focused on acquiring, developing and commercializing innovative pharmaceutical products that improve human health and quality of life. It's main research product, AB-106, is an oral, highly selective ROS1/NTRK small molecule inhibitor.
- Unknown
- BD@anhearttherapeutics.com
- Unknown
- anhearttherapeutics.com/en/home
- Not verified company
